We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Store
»
Authors
»
Vilmary Negron Rodriguez
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Training
Vilmary Negron Rodriguez
MSD International GmbH (Puerto Rico Branch) LLC
Price:
$117.00
View
Suzhou Homesum Pharmaceutical Co. Ltd.
Price:
$117.00
View
Hangzhou FaceCare Cosmetics Co., Ltd.
Price:
$117.00
View
Mary Kay, Inc.
Price:
$117.00
View
Amgen Manufacturing Ltd.
Price:
$117.00
View
MSN Laboratories Pvt. Ltd.
Price:
$117.00
View
Warner Chilcott Co.
Price:
$117.00
View
MSN Laboratories Pvt., Ltd.
Price:
$117.00
View
Upcoming Events
23
Sep
Data Integrity in the COVID-19 Era and Beyond — Part II: Key Issues in Data Integrity: Today and Tomorrow
23
Sep
Diversifying Clinical Trial Participation: Effective Strategies for Identifying and Recruiting Diverse Patient Participants
24
Sep
Domestic Inspections and Risk Assessment: What’s the Same and What’s Different with the FDA’s Resumed Operations?
29
Sep
Permitted Daily Exposure/Acceptable Daily Exposure Values: The New Acceptance Criteria in Cleaning Validation
30
Sep
POCs, IVDs and LDTs — Way More than Alphabet Soup: What Medical Device Professionals Need to Know for Premarket Approval
07
Oct
17th Annual Medical Device Quality vCongress
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Eli Lilly’s Investigational Antibody Shows Promise as Outpatient COVID-19 Treatment
EuroBio Scientific Earns CE Mark for COVID-19/Flu/RSV Test
NIH Launches Trial of Rigel’s Fostamatinib for COVID-19 Patients
FDA Clears 410 Medical’s Rapid-Infusion Device for Blood
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
